1,2,5-oxadiazole N-oxide derivatives as potential anti-cancer agents:: synthesis and biological evaluation.: Part IV

被引:64
作者
Boiani, M
Cerecetto, H [1 ]
González, M
Risso, M
Olea-Azar, C
Piro, OE
Castellano, EE
de Ceráin, AL
Ezpeleta, O
Monge-Vega, A
机构
[1] Univ Republica, Fac Quim, Dept Quim Organ, Montevideo, Uruguay
[2] Univ Republica, Fac Ciencias, Dept Quim Organ, Montevideo, Uruguay
[3] Univ Chile, Fac Ciencias Quim & Farmacuet, Dept Quim Inorgan & Analit, Santiago, Chile
[4] Univ Nacl La Plata, La Plata, Buenos Aires, Argentina
[5] Consejo Nacl Invest Cient & Tecn, Inst IFLP, Dept Fis, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina
[6] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil
[7] Univ Navarra, Fac Farm, Ctr Invest Farmacobiol Aplicada, E-31080 Pamplona, Spain
基金
巴西圣保罗研究基金会;
关键词
1,2,5-oxadiazole N-oxide; anti-cancer agents; structure-activity relationships;
D O I
10.1016/S0223-5234(01)01265-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several new 1,2,5-oxadiazole N-oxide derivatives and some deoxygenated analogues were synthesized to be tested as potential selective hypoxic cell cytotoxins. Compounds prepared were designed in order to gain insight into the mechanism of action of this kind of cytotoxin. Compounds were tested in oxia and hypoxia and they proved to be non-selective. 3-Cyano-N-2-oxide-4-phenyl-1,2,5-oxadiazole showed the best cytotoxic activity in oxia. The cytotoxicity observed for these derivatives could be explained in terms of the electronic characteristics of the 1,2,5-oxadiazole substituents. Electrochemical and ESR studies were performed on the more cytotoxic derivative, (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:771 / 782
页数:12
相关论文
共 47 条
[1]   Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554) [J].
Aboagye, EO ;
Lewis, AD ;
Tracy, M ;
Workman, P .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (11) :1217-1224
[2]   5-nitrofuran-2-ylmethyl group as a potential bioreductively activated pro-drug system [J].
Berry, JM ;
Watson, CY ;
Whish, WJD ;
Threadgill, MD .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1997, (08) :1147-1156
[3]   Nicorandil analogues containing NO-donor furoxans and related furazans [J].
Boschi, D ;
Cena, C ;
Di Stilo, A ;
Fruttero, R ;
Gasco, A .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (07) :1727-1732
[4]   DEOXYGENATION OF AROMATIC O-DINITROSO DERIVATIVES BY PHOSPHINES [J].
BOYER, JH ;
ELLZEY, SE .
JOURNAL OF ORGANIC CHEMISTRY, 1961, 26 (11) :4684-&
[5]   SR-4233 (TIRAPAZAMINE) - A NEW ANTICANCER DRUG EXPLOITING HYPOXIA IN SOLID TUMORS [J].
BROWN, JM .
BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1163-1170
[6]   Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies [J].
Brown, JM .
MOLECULAR MEDICINE TODAY, 2000, 6 (04) :157-162
[7]   Hypoxia-specific cytotoxins in cancer therapy [J].
Brown, JM ;
Sum, BG .
SEMINARS IN RADIATION ONCOLOGY, 1996, 6 (01) :22-36
[8]   DEAMINATION OF NERYLAMINE AND GERANYLAMINE [J].
BUNTON, CA ;
HACHEY, DL ;
LERESCHE, JP .
JOURNAL OF ORGANIC CHEMISTRY, 1972, 37 (25) :4036-4039
[9]  
Cerecetto H, 2000, ARCH PHARM, V333, P387
[10]   1,2,5-oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs:: Structure-activity relationships [J].
Cerecetto, H ;
Di Maio, R ;
González, M ;
Risso, M ;
Saenz, P ;
Seoane, G ;
Denicola, A ;
Peluffo, G ;
Quijano, C ;
Olea-Azar, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (11) :1941-1950